Established MOTS-c stacks
Metabolic Optimization
Goal: Layered metabolic and mitochondrial signaling research
Investigators have considered pairing MOTS-c with GLP-1 agonists in metabolic syndrome models. Not a clinical regimen.
How to think about stacking
- Mechanism diversity beats redundancy. Pairing compounds that hit different pathways usually outperforms stacking two compounds with similar mechanisms.
- Track one variable at a time. Starting two peptides simultaneously makes it impossible to attribute effects. Research protocols typically introduce stacks sequentially.
- Side-effect interactions. Some peptides compound each other's side effects (e.g., GLP-1 agonists with other GI-active compounds). Review side-effect profiles before stacking.